Diabetes

US Patent 20160058736 A1, Mar 3, 2016 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

​

US Patent 20160243075 A2, Aug 25, 2016 - Tetrahydrocannabivarin (THCv) for use in the protection of pancreatic islet cells

​

US Patent 8084422, Dec 27, 2011 - Method of treating insulin resistance with a selective inhibitor of CB2 receptor activity

​

Cannabis Derived Drug Shows Promise in Treating Type 2 Diabetes

Calhoun-Rice, Sandy, et al.

Healthline News. 2013 July 23, (online news article).

​

The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults

Penner, Elizabeth, et al.

The American Journal of Medicine. 2013 Jul 23, 126(7): 583-589 (Full).

​

The cannabinoid  Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity

Wargent, E.T., et al.

Nutrition & Diabetes. 2013 May 27, 3(5): 68 (Full).

​

Marijuana users have better blood sugar control

Penner, Elizabeth A, et al.

Elsevier. 2013 May 15, (online news article). 

​

Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III 

Rajavashisth, Tripathi, et al.

BMJ Open: Diabetes and endocrinology. 2012 Feb, 2(1) (Online Article). 

​

The role of cannabis and cannabinoids in diabetes

Frisher, Martin, et al.

The British Journal of Diabetes & Vascular Disease. 2010 Dec, 10(6): 267-273 (Full).

​

Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory Cell Death Signaling Pathways in Diabetic Cardiomyopathy

Rajesh, Mohanraj, et al.

Journal of the American College of Cardiology. 2010 Dec, 56(25): 2115-2125 (Full). 

​

Randomized Placebo-Controlled Double-Blind Clinical Trial of Cannabis-Based Medicinal Product (Sativex) in Painful Diabetic Neuropathy 

Selvaraja, Dinesh, et al.

Diabetes Care, American Diabetes Association website. 2010 Jan, 33(1): 128-130 (Full).

​

Neuroprotective and Blood-Retinal Barrier Preserving Effects of Cannabidiol in Experimental Diabetes 

El-Remessy, Azza B, et al.

The American Journal of Pathology: Cellular and Molecular Biology of Disease. 2006 Jan, 168(1): 235-244 (Full). 

​

Beneficial effects of a Cannabis Sativa extract treatment on diabetes-induced neuropathy and oxidative stress

Comelli, Francesca, et al.

Phytotherapy Research. 2009 Dec, 23(12): 1678-1684 (abstract).  

​

Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes

Gallant, M, et al.

Phytomedicine: International Journal of Phytotherapy and Phytopharmacology. 2009 July 24, 16(10): 942-949 (abstract).

​

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice 

Weiss, L, et al.

Autoimmunity. 2006, 39(2): 143-151 (abstract). 

​

Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?

Croxford, JL, et al.

Journal of Neuroimmunology. 2005 Sep, 166(1-2): 3-18 (abstract). 

​

Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect

Dogrul, A, et al.

Neuroscience Letters. 2004 Sep 16, 368(1): 82 (abstract).